ARCHIVES

Economic Analyses Of New Therapies Useful In Phase III Studies, Trialists Say

This article is from The Cancer Letter archive.

Vol. 35 No. 29 | July 24, 2009

Download PDF Visit The Full Archive

Related Articles

In Brief: NCI To Supply Maytansine For Several Phase I Studies; Holleb Urges Referrals To “Experts”

March 26, 1976

DOD funds $4.2 million gynecologic oncology research program at four institutions.

July 2, 2004

Court Filing By Fisher; Board, Attacks Interim NSABP Leadership

August 12, 1994

Plan To Reprogram $10 Million On Construction Funds Draws Criticism

November 19, 1976

Letrozole Cuts Risk Of Breast Cancer Recurrence Even After Tamoxifen Use

March 28, 2008

In Brief: Clark Wins Sheen award; Research Training Cuts Prompt PhD Holders To Apply Medical Schools

July 12, 1974